These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36432016)

  • 1. Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review.
    Kumi RO; Oti B; Abo-Dya NE; Alahmdi MI; Soliman MES
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.
    Favuzza P; de Lera Ruiz M; Thompson JK; Triglia T; Ngo A; Steel RWJ; Vavrek M; Christensen J; Healer J; Boyce C; Guo Z; Hu M; Khan T; Murgolo N; Zhao L; Penington JS; Reaksudsan K; Jarman K; Dietrich MH; Richardson L; Guo KY; Lopaticki S; Tham WH; Rottmann M; Papenfuss T; Robbins JA; Boddey JA; Sleebs BE; Sabroux HJ; McCauley JA; Olsen DB; Cowman AF
    Cell Host Microbe; 2020 Apr; 27(4):642-658.e12. PubMed ID: 32109369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax.
    Hodder AN; Christensen J; Scally S; Triglia T; Ngo A; Birkinshaw RW; Bailey B; Favuzza P; Dietrich MH; Tham WH; Czabotar PE; Lowes K; Guo Z; Murgolo N; Lera Ruiz M; McCauley JA; Sleebs BE; Olsen D; Cowman AF
    Structure; 2022 Jul; 30(7):947-961.e6. PubMed ID: 35460613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azole-based non-peptidomimetic plasmepsin inhibitors.
    Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria.
    de Lera Ruiz M; Favuzza P; Guo Z; Zhao L; Hu B; Lei Z; Zhan D; Murgolo N; Boyce CW; Vavrek M; Thompson J; Ngo A; Jarman KE; Robbins J; Boddey J; Sleebs BE; Lowes KN; Cowman AF; Olsen DB; McCauley JA
    ACS Med Chem Lett; 2022 Nov; 13(11):1745-1754. PubMed ID: 36385924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
    Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
    Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE
    Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites.
    Birnbaum J; Scharf S; Schmidt S; Jonscher E; Hoeijmakers WAM; Flemming S; Toenhake CG; Schmitt M; Sabitzki R; Bergmann B; Fröhlke U; Mesén-Ramírez P; Blancke Soares A; Herrmann H; Bártfai R; Spielmann T
    Science; 2020 Jan; 367(6473):51-59. PubMed ID: 31896710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New dimensions in the field of antimalarial research against malaria resurgence.
    Narula AK; Azad CS; Nainwal LM
    Eur J Med Chem; 2019 Nov; 181():111353. PubMed ID: 31525705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian Deubiquitinating Enzyme Inhibitors Display
    Simwela NV; Hughes KR; Rennie MT; Barrett MP; Waters AP
    ACS Infect Dis; 2021 Feb; 7(2):333-346. PubMed ID: 33400499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
    Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
    Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current scenario and future strategies to fight artemisinin resistance.
    Pasupureddy R; Atul ; Seshadri S; Pande V; Dixit R; Pandey KC
    Parasitol Res; 2019 Jan; 118(1):29-42. PubMed ID: 30478733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of
    Lowe MA; Cardenas A; Valentin JP; Zhu Z; Abendroth J; Castro JL; Class R; Delaunois A; Fleurance R; Gerets H; Gryshkova V; King L; Lorimer DD; MacCoss M; Rowley JH; Rosseels ML; Royer L; Taylor RD; Wong M; Zaccheo O; Chavan VP; Ghule GA; Tapkir BK; Burrows JN; Duffey M; Rottmann M; Wittlin S; Angulo-Barturen I; Jiménez-Díaz MB; Striepen J; Fairhurst KJ; Yeo T; Fidock DA; Cowman AF; Favuzza P; Crespo-Fernandez B; Gamo FJ; Goldberg DE; Soldati-Favre D; Laleu B; de Haro T
    J Med Chem; 2022 Oct; 65(20):14121-14143. PubMed ID: 36216349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and modelling of photoreactive chemical probes for investigating target engagement of plasmepsin IX and X in
    Lisauskaitė M; Nixon GL; Woodley CM; Berry NG; Coninckx A; Qie LC; Leung SC; Taramelli D; Basilico N; Parapini S; Ward SA; Vadas O; Soldati-Favre D; Hong WD; O'Neill PM
    RSC Chem Biol; 2024 Jan; 5(1):19-29. PubMed ID: 38179191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.